eMed® is the leader in Population Health GLP-1/GIP benefit programs and chronic care management related to obesity and type 2 diabetes. eMed provides cost effective GLP-1/GIP benefits for employers and 24/7 support to employees. The eMed GLP-1/GIP Program Screening Kit™ makes it easy for employees to test and screen at home with the guidance of trained Live Virtual Proctors. Screening results are clinically reviewed and qualified employees receive monthly prescriptions, 24/7 side-effect support and weekly check-ins to enhance medication adherence. The company is revolutionizing employer GLP-1/GIP benefit programs to improve employee health outcomes and manage benefit costs. Learn more at www.eMed.com.
Our team is over 100 strong. We combine experience from a multitude of domain areas across leading healthcare services. This combination gives us a special edge to drive clinical excellence. It is also why our technology will continue to expand to various use cases that address a broader range of conditions, making healthcare accessible and affordable for both consumers and enterprises.